#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Superficial vein thrombosis B-cell small lymphocytic lymphoma Hyperchylomicronaemia Arginase deficiency Neutropenia Chronic lymphocytic leukaemia refractory Ureteric cancer Cold type haemolytic anaemia Arterial tortuosity syndrome Systemic candida Fungal infection Congenital pseudarthrosis Chondrodystrophy Frontotemporal dementia Osteopetrosis More trials…

    Learn about Rare Diseases

    Erdheim-Chester disease – Treatment Angiosarcoma – Trials in Disease Lymphatic malformation Biotinidase deficiency – Treatment Piriformis syndrome – Basic Information Stevens-Johnson syndrome – Basic Information Stevens-Johnson syndrome – Diagnostics Mantle cell lymphoma Andersen-Tawil syndrome – Treatment Metachromatic leukodystrophy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Exemestane ALLO-QUADCAR01-T Casirivimab Darolutamide Sym024 Golexanolone LINAPRAZAN GLURATE Alirocumab Crofelemer Metamizole Magnesium Samuraciclib Ptc518 Doxycycline Monohydrate Zoledronic Acid Avb-101 Gemlapodect Amg 193 Savolitinib O15-Water Masofaniten More therapies…

    Learn about Your Condition

    Spinal pain Thrombolysis Rasmussen encephalitis Pulmonary vascular disorder Foot deformity Triple positive breast cancer Asthma Porphyria non-acute Lip and/or oral cavity cancer Noninfective chorioretinitis Femoral hernia Lichen sclerosus Hypoalbuminaemia Lower limb fracture Vertebrobasilar stroke More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on Long-Term Use of Spesolimab for Patients with Hidradenitis Suppurativa Who Completed a Previous Spesolimab Study

    Not recruiting

    4 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Spesolimab
    Austria Belgium Bulgaria Czechia Denmark Finland +8

  • Study on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Brodalumab
    Belgium Czechia France Germany Greece Hungary +3

  • Study on Abrocitinib for Patients with Moderate to Severe Chronic Hand Eczema Unresponsive to Corticosteroids

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hand dermatitis
    Investigated Drugs:
    • Abrocitinib
    Poland

  • Study on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis Using Topical Corticosteroids

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Amlitelimab
    • Pimecrolimus
    • Tacrolimus
    Bulgaria Czechia France Germany Italy Spain

  • Study of Enpatoran in Adults with Systemic Lupus Erythematosus (SLE) and Cutaneous Lupus Erythematosus (CLE)

    Not recruiting

    2 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    • Chronic cutaneous lupus erythematosus
    • Cutaneous lupus erythematosus
    Investigated Drugs:
    • Enpatoran
    Bulgaria Greece Poland Romania Spain

  • Study on 5-Fluorouracil and Calcipotriol for Treating Actinic Keratosis in Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Actinic keratosis
    Investigated Drugs:
    • Calcipotriol
    • Fluorouracil
    The Netherlands
Previous Page
1 … 50 51 52 53 54 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!